Drug development

Auto Added by WPeMatico

Using synthetic biology and AI to address global antimicrobial resistance threat

ai, AI (Artificial Intelligence), Antibiotics, Artificial Intelligence, Biological engineering, Collaboration, Drug development, Health sciences and technology, Institute for Medical Engineering and Science (IMES), Jameel Clinic, Research, School of Engineering, Synthetic biology

James J. Collins, the Termeer Professor of Medical Engineering and Science at MIT and faculty co-lead of the Abdul Latif Jameel Clinic for Machine Learning in Health, is embarking on a multidisciplinary research project that applies synthetic biology and generative artificial intelligence to the growing global threat of antimicrobial resistance (AMR).The research project is sponsored […]

Using synthetic biology and AI to address global antimicrobial resistance threat Read More »

3 Questions: Using AI to accelerate the discovery and design of therapeutic drugs

ai, AI (Artificial Intelligence), Antibiotics, Artificial Intelligence, Bacteria, Biological engineering, Broad Institute, Collaboration, Computer science and technology, Disease, Drug development, Faculty, Harvard-MIT Health Sciences and Technology, Health sciences and technology, Institute for Medical Engineering and Science (IMES), Interview, Jameel Clinic, Microbes, School of Engineering, Synthetic biology

In the pursuit of solutions to complex global challenges including disease, energy demands, and climate change, scientific researchers, including at MIT, have turned to artificial intelligence, and to quantitative analysis and modeling, to design and construct engineered cells with novel properties. The engineered cells can be programmed to become new therapeutics — battling, and perhaps

3 Questions: Using AI to accelerate the discovery and design of therapeutic drugs Read More »

MIT scientists debut a generative AI model that could create molecules addressing hard-to-treat diseases

Artificial Intelligence, Computer Science and Artificial Intelligence Laboratory (CSAIL), Computer science and technology, Drug development, Electrical engineering and computer science (EECS), Health sciences and technology, Jameel Clinic, Machine Learning, Medicine, MIT Schwarzman College of Computing, Pharmaceuticals, Proteins, Research, School of Engineering, Special events and guest speakers

More than 300 people across academia and industry spilled into an auditorium to attend a BoltzGen seminar on Thursday, Oct. 30, hosted by the Abdul Latif Jameel Clinic for Machine Learning in Health (MIT Jameel Clinic). Headlining the event was MIT PhD student and BoltzGen’s first author Hannes Stärk, who had announced BoltzGen just a few days

MIT scientists debut a generative AI model that could create molecules addressing hard-to-treat diseases Read More »

AI maps how a new antibiotic targets gut bacteria

Algorithms, Antibiotics, Artificial Intelligence, Bacteria, Computer Science and Artificial Intelligence Laboratory (CSAIL), Computer science and technology, Disease, Drug development, Drug discovery, Electrical engineering and computer science (EECS), Health care, Health sciences and technology, Jameel Clinic, Machine Learning, Medicine, MIT Schwarzman College of Computing, Research, School of Engineering, Viruses

For patients with inflammatory bowel disease, antibiotics can be a double-edged sword. The broad-spectrum drugs often prescribed for gut flare-ups can kill helpful microbes alongside harmful ones, sometimes worsening symptoms over time. When fighting gut inflammation, you don’t always want to bring a sledgehammer to a knife fight.Researchers at MIT’s Computer Science and Artificial Intelligence

AI maps how a new antibiotic targets gut bacteria Read More »